Literature DB >> 11679939

Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.

R Ullmann1, S Petzmann, A Sharma, P T Cagle, H H Popper.   

Abstract

Large-cell neuroendocrine carcinoma (LCNEC) and small-cell lung cancer (SCLC) are high-grade neuroendocrine tumors of the lung. Despite different morphologic appearances, loss of heterozygosity and oncogene studies on LCNEC to date suggest genetic similarities. We analyzed 13 LCNEC and 5 mixed SCLC/LCNEC tumors by comparative genomic hybridization and subsequently compared our results with previously published data on 32 SCLCs. Comparison with SCLC showed several shared chromosomal aberrations, specifically losses of 3p, 4q, 5q, and 13q and gains of 5p. However, these aberrations are no special feature of neuroendocrine lung tumors but can also be found in other high-grade lung carcinomas. From this point of view, genetic similarities of LCNEC and SCLC are less important than the nonrandom changes that differ between these 2 tumor types. A gain of 3q observed in 66% of all SCLCs was detected only once in the LCNEC group. In contrast to the pure LCNEC, all mixed types with a SCLC component had a gain of 3q. Gains of 6p occurred more frequently in LCNEC. Deletions of 10q, 16q, and 17p were less frequent in LCNEC than in SCLC. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679939     DOI: 10.1053/hupa.2001.28248

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.

Authors:  Giuseppe Pelosi; Aldo Scarpa; Giulia Veronesi; Lorenzo Spaggiari; Barbara Del Curto; Patrick S Moore; Patrick Maisonneuve; Angelica Sonzogni; Michele Masullo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

Review 2.  Treatment of lung large cell neuroendocrine carcinoma.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-03-04

3.  Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.

Authors:  Wael Abdo Hassan; Shin-Ichiro Takebayashi; Mohamed Osama Ali Abdalla; Kosuke Fujino; Shinji Kudoh; Yamoto Motooka; Yonosuke Sato; Yoshiki Naito; Koichi Higaki; Joeji Wakimoto; Seiji Okada; Mituyoshi Nakao; Yuichi Ishikawa; Takaaki Ito
Journal:  Lab Invest       Date:  2017-04-17       Impact factor: 5.662

Review 4.  [Neuroendocrine tumors of the lung].

Authors:  K-M Müller
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

5.  [CGH findings in neuroendocrine tumours of the lung].

Authors:  G Johnen; M Krismann; M Jaworska; K-M Müller
Journal:  Pathologe       Date:  2003-05-15       Impact factor: 1.011

Review 6.  Update on large cell neuroendocrine carcinoma.

Authors:  Kenzo Hiroshima; Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2017-10

7.  CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.

Authors:  Giuseppe Pelosi; Michele Masullo; Maria Elena Leon; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Angelica Sonzogni; Antonio Iannucci; Enrica Bresaola; Giuseppe Viale
Journal:  Virchows Arch       Date:  2004-09-16       Impact factor: 4.064

8.  Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma.

Authors:  Giovanni Fellegara; Tiziana D'Adda; Francesco P Pilato; Elisabetta Froio; Luca Ampollini; Michele Rusca; Guido Rindi
Journal:  Virchows Arch       Date:  2008-06-13       Impact factor: 4.064

9.  Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.

Authors:  Juliane Rieber; Julian Schmitt; Arne Warth; Thomas Muley; Jutta Kappes; Florian Eichhorn; Hans Hoffmann; Claus Peter Heussel; Thomas Welzel; Jürgen Debus; Michael Thomas; Martin Steins; Stefan Rieken
Journal:  Eur J Med Res       Date:  2015-08-14       Impact factor: 2.175

Review 10.  Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy.

Authors:  Helmut Popper; Luka Brcic
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.